Drug reactions in therapeutics
Nahum, L.H.
Connecticut Medicine 35(8): 518-520
1971
ISSN/ISBN: 0010-6178 PMID: 5105687 Document Number: 34604
Document emailed within 1 workday
Related Documents
Bernstein, J.A. 1995: Nonimmunologic adverse drug reactions. how to recognize and categorize some common reactions Postgraduate Medicine 98(1): 120-122; 125-126Hooper, W.D.; Tyrer, J.H.; Eadie, M.J. 1976: Plasma drug concentrations in therapeutics Medical Journal of Australia 1(10): 313-319
Vickers, M.D. 1995: Monographs in the Drug and Therapeutics Bulletin. Seem to be biased Bmj 310(6980): 663
Davidson, K.W.; Kahn, A.; Price, R.D. 1987: Reduction of adverse drug reactions by computerized drug interaction screening Journal of Family Practice 25(4): 371-375
Plichta, D.; Doryńska, A.; Spiewak, R.ła. 2012: Patterns of drug consumption and the occurrence of adverse drug reactions among students of public health Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 32(190): 232-237
Jennum, P.; Kristensen, M.B. 1985: Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983 Ugeskrift for Laeger 147(32): 2539-2541
Pleasants, R.A.; Kessler, J.M. 1993: Drug allergies, adverse drug reactions, and the patient record American Journal of Hospital Pharmacy 50(7): 1363
Doña, I.; Blanca-López, N.; Torres, M.J.; García-Campos, J.; García-Núñez, I.; Gómez, F.; Salas, M.; Rondón, C.; Canto, M.G.; Blanca, M. 2012: Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients Journal of Investigational Allergology and Clinical Immunology 22(5): 363-371
Skipper, H.E.; Schabel, F.M.; Lloyd, H.H. 1978: Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells Seminars in Hematology 15(3): 207-219
Gopalani, V. 2005: Web sites on adverse drug reactions and drug interactions Indian Journal of Dermatology Venereology and Leprology 71(1): 60-62
Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Koritz, G.D. 1995: American Academy of Veterinary Pharmacology and Therapeutics: perspectives on the utility of flexible drug labeling. An AAVPT perspective: Part I Journal of the American Veterinary Medical Association 207(7): 875-876
Sui, M.; Cui, L. 2017: Constructing a Gene-Drug-Adverse Reactions Network and Inferring Potential Gene-Adverse Reactions Associations Using a Text Mining Approach Studies in Health Technology and Informatics 245: 531-535
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Chuchottaworn, C.; Saipan, B.; Kittisup, C.; Cheewakul, K. 2012: Adverse drug reactions and outcome of short course anti-tuberculosis drugs between single daily dose and split drug dose (BID) in pulmonary tuberculosis Journal of the Medical Association of Thailand 95(Suppl 8): S1-S5
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
D'Arcy, P.F. 1987: Drug reactions and interaction Journal de Pharmacie de Belgique 42(4): 281-285
Naess, K. 1975: Responsibility for drug reactions Nordisk Medicin 90(3): 65-66
Renoz, L. 1984: Drug reactions and interactions Journal de Pharmacie de Belgique 39(1): 63-65
Loucopoulos, N.; Gellis, D.; Gkeles, D. 1974: Allergic drug reactions in dentistry Stomatologia 31(2): 105-117